| Literature DB >> 34424407 |
Ryan K Thorpe1, Hela Azaiez1, Peina Wu2, Qiuju Wang3, Lei Xu4, Pu Dai5, Tao Yang6, G Bradley Schaefer7, B Robert Peters8, Kenny H Chan9, Krista S Schatz10, Joann Bodurtha10, Nathaniel H Robin11, Yoel Hirsch12, Zuhair Abdalla Rahbeeni13, Huijun Yuan14, Richard J H Smith15,16.
Abstract
Pathogenic variations in the OTOF gene are a common cause of hearing loss. To refine the natural history and genotype-phenotype correlations of OTOF-related auditory neuropathy spectrum disorders (ANSD), audiograms and distortion product otoacoustic emissions (DPOAEs) were collected from a diverse cohort of individuals diagnosed with OTOF-related ANSD by comprehensive genetic testing and also reported in the literature. Comparative analysis was undertaken to define genotype-phenotype relationships using a Monte Carlo algorithm. 67 audiograms and 25 DPOAEs from 49 unique individuals positive for OTOF-related ANSD were collected. 51 unique OTOF pathogenic variants were identified of which 21 were missense and 30 were loss of function (LoF; nonsense, splice-site, copy number variants, and indels). There was a statistically significant difference in low, middle, and high frequency hearing thresholds between missense/missense and LoF/missense genotypes as compared to LoF/LoF genotypes (average hearing threshold for low, middle and high frequencies 70.9, 76.0, and 73.4 dB vs 88.5, 95.6, and 94.7 dB) via Tukey's test with age as a co-variate (P = 0.0180, 0.0327, and 0.0347, respectively). Hearing declined during adolescence with missense/missense and LoF/missense genotypes, with an annual mid-frequency threshold deterioration of 0.87 dB/year and 1.87 dB/year, respectively. 8.5% of frequencies measured via DPOAE were lost per year in individuals with serial tests. Audioprofiling of OTOF-related ANSD suggests significantly worse hearing with LoF/LoF genotypes. The unique pattern of variably progressive OTOF-related autosomal recessive ANSD may be amenable to gene therapy in selected clinical scenarios.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34424407 PMCID: PMC9093589 DOI: 10.1007/s00439-021-02340-w
Source DB: PubMed Journal: Hum Genet ISSN: 0340-6717 Impact factor: 5.881